Abstract

Commonly used tests to detect carcinogenic potential of a test compound make extreme assumptions about the lethality of tumors, due to their occult nature. In this paper we compare a nonparametric test, which uses interim sacrifice to avoid such assumptions, with these tests using simulation based on the EDOl data. Results indicate that in the presence of a significant difference in the mortality rate with treatment, commonly used methods could fail to maintain the nominal significance level. However, when there is no difference in the mortality rate, such procedures are robust to the underlying assumptions about the lethality of tumors and more powerful than the nonparametric test using interim sacrifice.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.